Subsequently, a Phase 2 clinical trial on the combination of PHY906 with chemotherapy (capecitabine) in patients with advanced hepatocellular carcinoma showed PHY906 increased the therapeutic index of capecitabine by enhancing its antitumor activity and reducing its toxicity profile [23]
Micioni Di Bonaventura, E., Botticelli, L., Del Bello, F., Giorgioni, G., Piergentili, A., Quaglia, W., Romano, A., Gaetani, S., Micioni Di Bonaventura, M
Clinical trials have demonstrated impressive results
What Causes GLP-1 Injection Site Reactions Understanding the reasons behind injection site reactions can help reduce their occurrence
Current principles of motor control, with special reference to vertebrate locomotion